Results 291 to 300 of about 251,408 (329)
Some of the next articles are maybe not open access.
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
The Lancet, 2017 P. Joly, M. Maho-Vaillant, C. Prost-Squarcioni, V. Hébert, E. Houivet, S. Calbo, F. Caillot, M. Golinski, B. Labeille, C. Picard‐Dahan, C. Paul, M. Richard, J. Bouaziz, S. Duvert‐Lehembre, P. Bernard, F. Caux, M. Alexandre, S. Ingen‐Housz‐Oro, Pierre Vabres, E. Delaporte, G. Quéreux, A. Dupuy, S. Debarbieux, M. Avenel‐Audran, M. D’Incan, C. Bédane, N. Bénéton, D. Jullien, N. Dupin, L. Miséry, L. Machet, M. Beylot‐Barry, O. Dereure, B. Sassolas, T. Vermeulin, J. Benichou, P. Musette +36 moresemanticscholar +1 more sourceObinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.
Journal of Clinical Oncology, 2017 U. Vitolo, M. Trněný, D. Belada, J. Burke, A. Carella, N. Chua, P. Abrisqueta, J. Demeter, I. Flinn, X. Hong, W. Kim, A. Pinto, Yuankai Shi, Y. Tatsumi, M. Oestergaard, M. Wenger, G. Fingerle-Rowson, O. Catalani, T. Nielsen, M. Martelli, L. Sehn +20 moresemanticscholar +1 more sourceChemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
Journal of Clinical Oncology, 1996 I. Tannock, D. Osoba, M. Stockler, D. Ernst, A. Neville, M. J. Moore, G R Armitage, J. Wilson, P. Venner, C. Coppin, K. Murphy +10 moresemanticscholar +1 more sourceMycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
American Journal of Kidney Diseases, 2017 Jin-Hua Hou, W. Le, N. Chen, Weiming Wang, Zhang-Suo Liu, Dong Liu, Jiang‐hua Chen, Jiong Tian, P. Fu, Zhang-Xue Hu, C. Zeng, S. Liang, Minlin Zhou, Haitao Zhang, Zhi-Hong Liu +14 moresemanticscholar +1 more source